Press Release Headlines

Specialty Pharmaceutical Distributor BDI Pharma Officially Opens National Distribution Center in Texas

Company increases cold chain capacity to more than double with newly licensed facility near DFW Airport.

COLUMBIA, S.C., Dec. 8, 2014 /PRNewswire/ — BDI Pharma, Inc. announced today the licensure of a new national distribution center located in Irving, Texas.  The new facility more than doubles the company's cold chain, shipping and storage capabilities while providing additional safeguards in maintaining business continuity and uninterrupted supply chain.

Photo – http://photos.prnewswire.com/prnh/20141205/162714

Photo – http://photos.prnewswire.com/prnh/20141205/162715

"This is truly an exciting time for us at BDI as we gear up for another successful year in 2015," states Edward Stiefel, President of BDI Pharma.  "In order to meet increasing customer, manufacturer and contracting demands, not only in the local market but nationally, the addition of this new D.C. was vital to sustaining the record growth we have experienced over the last two decades."

Company officials are estimating that roughly one third of their outbound shipments will come from the new Texas location.  Manuel Martinez, Vice President of Operations for BDI Pharma adds, "At any given time this location can also serve to back up our corporate facilities with operational redundancy."

The new distribution center is located in close proximity to DFW Airport, providing the delivery capabilities that BDI Pharma demands for its customers, and also serving to expand the company's normal hours of operations.

About BDI Pharma, Inc.

BDI Pharma has continuously refined the concept of niche distribution, providing solutions beyond the traditional wholesaler model since 1995.  We operate as an extension of our partners' sales force, create demand, and move market share with each transaction.  In this regard, we maintain a highly selective process when entering into a strategic partnership.  Our approach of serving the manufactures as well as healthcare providers and patients over the last two decades has proven successful regardless of varying market conditions.  This is further supplemented through innovative supply solutions, extensive product knowledge, 24/7 emergency availability and urgent need delivery.  The company's website www.bdipharma.com serves as an invaluable resource for reference material, educational literature and online ordering.  Proprietary programs offering comprehensive reimbursement services – www.bdiaccess.com and 855-BDI-CARE; and product consignment – www.bdivantageplus.com; are just a few of the solutions tailored to the needs of the entire healthcare community.

BDI Pharma's product portfolio includes IVIG, branded and generic specialty pharmaceuticals, chemotherapy, vaccines, albumin, coagulation factors, high-titer or "hyper" immune globulins, and other niche, specialty products.  BDI Pharma is recognized as an "ADR," or Authorized Distributor of Record, for all of the manufacturers it represents.

Media Contact:
Brad Davis
800-948-9834
Email